The CTN’s HIV and Aging Cohort Study aims to understand how HIV can affect the development of heart…
By the end of September 2022, there will no longer be blood donation criteria specific to men who…
Dr. Cara Spence began her CTN Postdoctoral Fellowship in 2021, sponsored by CANFAR, embarking on a project investigating…
Understanding COVID-19 vaccine confidence in people living with HIV in Canada
April 24–30 is Canadian Infertility Awareness Week. It wasn’t that long ago that people living with HIV faced…

To mark International Women’s Day, we sat down with the CTN 335 investigators to learn about how their…
The drug works against CMV, a common virus that may be a main cause of inflammation and health…
Ahead of World Cancer Day, we spoke with Dr. Troy Grennan about anal cancer screening among gbMSM living…

A new national study, called HIVCOV (CTN 328), will assess COVID-19 vaccine immune responses and effectiveness among people…
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
This course aims to develop in-depth knowledge of HIV treatment for frontline service providers. Participants learn how HIV treatment works in the body, what being on HIV treatment means, how HIV develops drug resistance and how to support clients with adherence.
This course is delivered online by a CATIE health educator, providing instruction through a combination of interactive e-learning units, readings, videos, and discussion board assignments. The course culminates in an online meeting where participants can learn and discuss implications for their daily work.
HIV in Canada: 2022 surveillance highlights
The Public Health Agency of Canada’s integrated bio-behavioural surveillance system—Tracks surveys—assesses the burden of HIV, hepatitis C and associated risks in key populations in Canada
Summary of the provincial and territorial coverage of antiretroviral therapy in Canada. Data was collected from secondary data sources between September and December 2022
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People with HIV
Project ReportNeedles.ca: A rapid assessment and response system to map needle prevalence and implement harm reduction interventions in Regina, Saskatchewan
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.